Effects of tramadol and its enantiomers on Concanavalin-A induced-proliferation and NK activity of mouse splenocytes: Involvement of serotonin

International Journal of Immunopharmacology

Volumn 21, Issue 11, 1999, Pages 727-734

  Sacerdote, P ^a   Bianchi, M ^a   Gaspani, L ^a   Panerai, A E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Immune functions; Lymphocytes; Mouse; Serotonin; Splenocytes; Tramadol

Indexed keywords

CONCANAVALIN A; METERGOLINE; TRAMADOL;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENANTIOMER; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SPLEEN CELL;

ANALGESICS, OPIOID; ANIMALS; CONCANAVALIN A; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; METERGOLINE; MICE; MITOGENS; SEROTONIN ANTAGONISTS; SPLEEN; STEREOISOMERISM; TRAMADOL;

EID: 0032842982     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00048-X     Document Type: Article

References (24)

1. Band L.C., Pert A., Williams W., de Costa B.R., Rice K.C., Weber R.J. Central μ-opioid receptors mediate suppression of natural killer activity in vivo. Progress in Neuroendocrineimmunology. 5:1992;95-101.
2. Bergquist J., Tarkowsky A., Ewing A., Elkman R. Catecholaminergic suppression of immunocompetent cells. Immunology Today. 19:1998;562-567.
3. Bessson J.M., Vickers M.D. Tramadol analgesia. Drugs. 47:1994;1-2.
4. Bryant U.H., Bernton E.W., Holaday J.W. Morphine pellet-induced immunomodulation in mice: temporal relationships. J. Pharmacol. Exp. Ther. 245:1988;913-920.
5. Clancy J., Petrovic L.M., Gordon B.H., Handa R.J., Campbell D.B., Lorens S.A. Effects of subchronic D-fenfluoramine treatment on splenic immune functions in young and old male and female F344 rats. J. Immunopharmacol. 13:1991;1203-1212.
6. Dayer P., Collart L., Desmeules J. The pharmacology of tramadol. Drugs. 47:1994;3-7.
7. Driessen B., Reimann W. Interaction of the central analgesic tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br. J. Pharmacol. 105:1992;147-151.
8. Driessen B., Reimann W., Giertz H. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br. J. Pharmacol. 108:1993;806-811.
9. Frink M.C., Henniesm H.H., Englbergerm W., Haurandm M., Wilffert B. Influence of tramadol on neurotrasmitter systems in the brain. Arzneim.-Forsch. 46:1996;1029-1036.
10. Gabrilovac J., Cicin-Sain L., Osmark M., Jernej B. Alteration of NK-and ADCC activities in rats genetically selected for low or high platelet serotonin level. J. Neuroimmunol. 37:1992;213-222.
11. Kayser V., Besson J.M., Guilbaud G. Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat. Eur. J. Pharmacol. 224:1992;83-88.
12. Livnat S., Felten S.Y., Carlson S.L., Bellinger D.L., Felten D.L. Involvement of peripheral and central Catecholamine systems in Neural-Immune Interactions. J. Neuroimmunol. 10:1985;5-30.
13. Lysle D.T., Coussons M.E., Watts V.J., Bennet E.H., Dykstra L.A. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265:1992;1071-1078.
14. Madden K.S., Moynihan J.A., Brenner G.J., Felten S.Y., Felten D.L., Livnat S. Sympathetic nervous system modulation of the immune system. III Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J. Neuroimmunol. 49:1994;77-87.
15. Manfredi B., Sacerdote P., Bianchi M., Locatelli L., Veljic-Radulovic J., Panerai A.E. Evidence for an opioid inhibitory effect on T cell proliferation. J. Neuroimmunol. 44:1993;43-48.
16. Mossner R., Lesch K.P. Role of serotonin in the Immune System and in Neuroimmune interaction. Brain Behav. Immun. 12:1998;249-271.
17. Panerai A.E., Manfredi B., Granucci F., Sacerdote P. The beta-endorphin inhibition of mitogen-induced splenocytes proliferation is mediated by central and peripheral paracrine/autocrine effects of the opioid. J. Neuroimmunol. 58:1995;71-76.
18. Peterson P.K., Molitor T.W., Chunc C.C. Mechanism of morphine-induced immunomodulation. Biochem. Pharmacol. 46:1993;343-348.
19. Raffa R.B., Friderichs E., Reimann W., Shank R.P., Codd E.E., Vaught J.L. Opioid and non opioid components independently contribute to the mechanisms of action of tramadol, an atypical opioid analgesic. J. Pharmacol. Exp. Ther. 260:1992;275-285.
20. Raffa R.B., Friderichs E., Reinman W., Shank R.P., Codd E.E., Vaught J.L., Jacoby H.I., Selve N. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J. Pharmacol. Exp. Ther. 267:1993;331-340.
21. Sacerdote P., Bianchi M., Manfredi B., Panerai A.E. Effects of Tramadol on immune responses and nociceptive thresholds in mice. Pain. 72:1997;325-330.
22. Sacerdote P., Manfredi B., Mantegazza P., Panerai A.E. Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Br. J. Pharmacol. 121:1997;834-840.
23. Steplewsky Z., Vogel W.H. Changes in serotonin levels affect leukocytes, lymphocytes, T cell subpopulation and natural killer cell activity in rats. Neurosci. Letters. 62:1985;277-282.
24. Taub D.D., Eisenstein T.K., Gellerm E.B., Adler M.W., Rogers T.J. Immunomodulatory activity of μ and κ-selective opioid agonists. Proc. Natl. Acad. Sci. USA. 88:1991;360-364.